latest posts
category
Newsletter
July 17, 2017
A Roadmap to the Death of Death
Might our ancestors be the last to have experienced death? Two cutting-edge scientists studying longevity and regenerative medicine are very hopeful. Intelligent Pharma has recently attended a seminar on cutting edge technology and research regarding the lengthening of human life. Read to find out how far today’s science has progressed in the field of lo...
April 18, 2017
Pythia 3.0
The newest version of PYTHIA, our in silico platform for polypharmacology and mode-of-action studies, is now available for licensing!   In a matter of seconds PYTHIA combines molecular similarity calculation based fingerprints with experimental activity data to identify biological and off-targets of an active compound. Default activity data come f...
February 20, 2017
Deep Neural Networks for drug discovery
Deep Neural Networks (DNNs) have been in the spotlight for last couple of years. This technique has been applied with great success to traditional Machine Learning problems such as Image and Speech recognition. Moreover, it has been applied to other learning problems such as mastering the game of Go being able to beat a human professional of this game for the ...
January 31, 2017
Improving drug discovery: the Human-On-Chip project
In our sector it is well known that the process of drug development takes on average 10-15 years to be completed, and it costs over $1 billion to finally launch a successful drug onto the market. Around 60-80% of drug discovery projects are unsuccessful: many drugs fail once they enter the clinical stages of the drug development process.   These f...
October 31, 2016
Polypharmacology and drug drug interactions
In the context of current demographics, with the percentage of the population age 60+ increasing and set to reach 2 billion people by 2050, the concept of drug drug interactions has become a hot topic. The increase in life expectancy comes with some challenges, as for example polymedication for chronic diseases.  With up to 40% of over 65 year olds curren...